USPTO serial 77551231
Serial No. 77551231
Reviewed by CopyMark Law Group
Reg. 4135778Status 710
- Filing date
- Status date
- Registration date
- May 1, 2012
- Examiner
- HENRY, NAKIA D
- Law office
- TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 77551231?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bruce S. Londa
Bruce S. Londa Norris, McLaughlin & Marcus, P.A.875 Third AvenueNew York, NY 10022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | printed reports and printed visuals, namely, information graphics providing statewide, market area, payer, hospital, and physician measurements on outcomes, quality, mortality, infections, complications, utilization, and price for use by third party payers, hospitals, physicians, healthcare organizations, insurance companies, HMOs, employers, legal counsel, the media, government entities and consumers | SECTION 8 - CANCELLED | Jul 31, 2008 |
| 035 | consulting services related to medical cost management; management services of a business nature for clinical trials in the field of investigational drugs; data compilation and analysis in the field of healthcare management, namely, conducting pharmacoeconomics, health economics and statistical research for business purposes; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business consulting services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; supply chain management, namely, tracking and management of clinical trial supplies and research materials used in such; providing statistical information and analysis via computer for use with clinical trial data for business purposes; business consultation services for the healthcare industry; business consulting in the field of clinical and health economic research services for healthcare companies; preparing statistical business reports resulting from clinical trials and laboratory data analysis; consultation in the field of patient recruitment; data preparation for business purposes, namely, preparation of medical and scientific data for use by insurance companies and third party medical reimbursement organizations | SECTION 8 - CANCELLED | Jul 31, 2008 |
| 042 | medical and scientific research, data collection and analysis in the nature of clinical research and conducting clinical trials in the fields of healthcare, medical care and pharmaceuticals; scientific research in the field of general health and medical and scientific research, namely, conducting clinical trials by providing clinical indicators calculated using medical claims data that are used to measure quality of medical care; compilation and analysis in the field of scientific and medical research, namely, conducting pharmacoeconomics, health economics, medical laboratory data analysis, and statistical medical research; pharmaceutical development services in the fields of molecular medicine; healthcare, namely, scientific research consulting for improved clinical trial design; medical research that analyzes data to identify patterns across patient groups or disease progression; pharmaceutical development, namely, design, research and development of drugs, pharmaceuticals and medicines for others; clinical development services for others, namely, research and consultation in the fields of pharmaceutical drug development and clinical trial design; medical laboratory data analysis, clinical diagnosis research and diagnostic testing research; preparation of reports and research concerning development of medicines, pharmaceuticals, genetics, biology, biotechnology and pharmaceutical drugs; consulting services in the fields of pharmaceuticals research, and biotechnology fields; providing an on-line database in the field of medical, pharmaceutical, and biotechnical research and analysis; management services of a scientific and technical nature for clinical trials in the field of investigational drugs, namely, conducting clinical protocols and trials for others; consulting services regarding scientific aspects of clinical trials of investigational drugs, namely, advising others on conducting clinical protocols and trials; technical writing for others of clinical trial reports; research and consultation in the clinical medical field, namely, research and analysis provided to healthcare providers, suppliers of medical devices and pharmaceutical products, and suppliers of medical software and medical information management services; medical quality evaluation services, namely, providing data collection, analysis, and reporting services for patient data, clinical information, treatment options and treatment success for the medical industry; providing an on-line computer database in the field of healthcare, namely, health and productivity research and analysis; assessment surveys for health and medical purposes, namely, in research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; quality evaluation services, namely, surveying patients to assess quality of life, burden of disease and overall satisfaction with access to medical care to determine service quality for the medical industry | SECTION 8 - CANCELLED | Jul 31, 2008 |
| 044 | consultation in the field of drug use testing services; consultation in the field of healthcare; providing pharmaceutical advice; providing an interactive on-line computer database in the field of medical diagnostics | SECTION 8 - CANCELLED | Jul 31, 2008 |
| 045 | consulting services in the field of research and analysis of drug prescription and associated data, namely, regulatory compliance consulting as it applies to prescription drug sampling | SECTION 8 - CANCELLED | Jul 31, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Humana Inc.
- Other trademarks owned by Humana Inc.
- Other trademarks owned by Humana Inc.
- Other trademarks owned by LEHIGH VALLEY HEALTH NETWORK, INC.
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 9, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 27, 2018 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 1, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 2, 2012 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 1, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 24, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 30, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED | — |
| Mar 29, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 28, 2012 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Mar 27, 2012 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 1, 2012 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 1, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 1, 2012 | IUAF | USE AMENDMENT FILED | — |
| Feb 1, 2012 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 31, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 22, 2011 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Dec 22, 2011 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Dec 22, 2011 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 17, 2011 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 16, 2011 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 6, 2010 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 1, 2010 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 16, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 16, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 13, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 13, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 22, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 20, 2010 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 20, 2010 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 20, 2010 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 31, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 31, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 31, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 7, 2009 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 7, 2009 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 7, 2009 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 4, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 17, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 9, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 9, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2008 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 25, 2008 | NWAP | NEW APPLICATION ENTERED | — |